🇺🇸 SoluMedrol in United States

383 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 383

Most-reported reactions

1. Dyspnoea — 50 reports (13.05%)
2. Infusion Related Reaction — 45 reports (11.75%)
3. Nausea — 44 reports (11.49%)
4. Pyrexia — 40 reports (10.44%)
5. Pruritus — 38 reports (9.92%)
6. Pain — 37 reports (9.66%)
7. Headache — 35 reports (9.14%)
8. Hypotension — 33 reports (8.62%)
9. Malaise — 31 reports (8.09%)
10. Fatigue — 30 reports (7.83%)

Source database →

Frequently asked questions

Is SoluMedrol approved in United States?

SoluMedrol does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for SoluMedrol in United States?

University of Utah is the originator. The local marketing authorisation holder may differ — check the official source linked above.